have reported that GSK3β can phosphorylate VDAC1 in tumour cells, reducing mitochondrial HK2 binding and so making the cells more sensitive to chemotherapeutic agents (Pastorino et al., 2005). This evidence concerns the gene HK2 and neoplasm.